통합검색
내가 찾은 검색어
'ARDS' 에 대한 통합검색결과 30건입니다.
한빛사30건
-
Cirsium japonicum leaf extract attenuated lipopolysaccharide-induced acute respiratory distress syndrome in mice via suppression of the NLRP3 and HIF1
- Phytomedicine Mar 02 2025, 140 S0944-7113(25)00241-7 | https://doi.org/10.1016/j.phymed.2025.156601
- 2025.03
- 생명과학
-
Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
- Nano Converg. Feb 03 2025, 12 (1) | https://doi.org/10.1186/s40580-025-00475-4
- 2025.02
- 생명과학
-
Advanced MicroRNA delivery for lung inflammatory therapy: surfactant protein A controls cellular internalisation and degradation of extracellular vesi
- Thorax Dec 04 2024, thorax-2024-221793 | https://doi.org/10.1136/thorax-2024-221793
- 2024.12
- 생명과학
-
The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases
- Proc. Natl. Acad. Sci. USA Jun 25 2024, 121 (26) | https://doi.org/10.1073/pnas.2319322121
- 2024.06
- 생명과학
-
Nitric oxide-assisted mucus-walking zwitterionic nanocomplexes for synergistic treatment of severe respiratory infectious disease
- Mater. Today Available online 12 December 2023 | https://doi.org/10.1016/j.mattod.2023.11.011
- 2023.12
- 바이오·의료융합
-
-
A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes
- Crit. Care 2023 Jul 5;27(1):263 | https://doi.org/10.1186/s13054-023-04552-0
- 2023.07
- 의약학
-
Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome
- J. Control. Release 2023 Jun 19;360:1-14 | https://doi.org/10.1016/j.jconrel.2023.06.018
- 2023.06
- 바이오·의료융합
-
Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema
- Exp. Mol. Med. 2023 Apr;55(4):794-805 | https://doi.org/10.1038/s12276-023-00966-6
- 2023.04
- 의약학
-
Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with
- BMC Med. 2023 Feb 10;21(1):47 | https://doi.org/10.1186/s12916-023-02765-2
- 2023.02
- 의약학
-
Corticosteroids in?H1N1, non-viral, and?COVID-19 ARDS
- Intensive Care Med. 2022 Dec;48(12):1809-1811 | doi: 10.1007/s00134-022-06891-y
- 2022.12
- 의약학
-
Specific upregulation of extracellular miR-6238 in particulate matter-induced acute lung injury and its immunomodulation
- J. Hazard. Mater. 2022 Nov 24;445:130466 | https://doi.org/10.1016/j.jhazmat.2022.130466
- 2022.11
- 생명과학
-
Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
- PLoS Pathog. Published: September 19, 2022 | https://doi.org/10.1371/journal.ppat.1010819
- 2022.09
-
Mucosal associated invariant T cells in ARDS: MAIT cells set fire to macrophages via cytokines
- Thorax Online issue publication August 17, 2022 | http://dx.doi.org/10.1136/thoraxjnl-2022-218696
- 2022.08
- 의약학
-
SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohor
- Ann. Rheum. Dis. 2022 Jul 25;annrheumdis-2022-222689.| http://dx.doi.org/10.1136/ard-2022-222689
- 2022.07
- 의약학
-
Altered distribution, activation and increased IL-17 production of mucosal-associated invariant T cells in patients with acute respiratory distres
- Thorax Available online 27 January 2022 | http://dx.doi.org/10.1136/thoraxjnl-2021-217724
- 2022.01
- 의약학
-
A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis
- Biomaterials Available online 22 June 2021, 120986 | https://doi.org/10.1016/j.biomaterials.2021.120986
- 2021.06
- 바이오·의료융합
-
Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm
- Nano Today Available online 8 April 2021 | https://doi.org/10.1016/j.nantod.2021.101149
- 2021.04
- 바이오·의료융합
-
[Letter]GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
- Signal Transduct. Target. Ther. Published: 17 November 2020, 5, 267, 2020 | https://doi.org/10.1038/s41392-020-00391-5
- 2020.11
- 바이오·의료융합
-
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm
- Biomaterials Available online 23 October 2020, 120389 | https://doi.org/10.1016/j.biomaterials.2020.120389
- 2020.10
- 바이오·의료융합
